⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4447524 | 1.00 | — | — | |
| SCHEMBL300789 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL1669691 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL15414358 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL2227950 | 0.97 | — | — | |
| Trifluoroacetic Acid SCHEMBL30388501 | 0.83 | CHIT1 (0.31) | — | |
| Trifluoroacetic Acid SCHEMBL16718050 | 0.83 | CHIT1 (0.31) | — | |
| Valine SCHEMBL2227890 | 0.82 | SLC7A5 (0.62) | — | |
| SCHEMBL30675661 | 0.80 | — | — | |
| Beta-Alanine SCHEMBL3195784 | 0.80 | GABRP (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 370 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114729004-B | Heterocyclic compounds | 日商泛美克斯股份有限公司 | 2025-06-03 | — | — | CN | claimed |
| EP-4426284-A1 | BENZODIOXANE MODULATORS OF LEUKOTRIENE A4 HYDROLASE (LTA4H) FOR PREVENTION AND TREATMENT OF AGING-ASSOCIATED DISEASES | Alkahest, Inc. (US) | 2024-09-11 | — | — | EP | claimed |
| CN-116964048-A | Bicyclic tetrahydroazepine derivatives for the treatment of cancer | 豪夫迈·罗氏有限公司 | 2023-10-27 | — | — | CN | claimed |
| WO-2023076679-A1 | BENZODIOXANE MODULATORS OF LEUKOTRIENE A4 HYDROLASE (LTA4H) FOR PREVENTION AND TREATMENT OF AGING-ASSOCIATED DISEASES | ALKAHEST, INC. (US) | 2023-05-04 | — | — | WO | claimed |
| US-20220402935-A1 | HETEROCYCLIC COMPOUND | FIMECS, INC. (JP) | 2022-12-22 | — | — | US | claimed |
| CN-114729004-A | Heterocyclic compounds | 日商泛美克斯股份有限公司 | 2022-07-08 | — | — | CN | claimed |
| US-20200376035-A1 | METHODS AND COMPOSITIONS COMPRISING CART AND A SMAC MIMETIC | UNIV PENNSYLVANIA (US) | 2020-12-03 | — | — | US | claimed |
| WO-2019165215-A1 | METHODS AND COMPOSITIONS COMPRISING CART AND A SMAC MIMETIC | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2019-08-29 | — | — | WO | claimed |
| CN-109021700-A | The preparation method of quantum dot ink and light emitting diode with quantum dots | TCL集团股份有限公司 | 2018-12-18 | — | — | CN | claimed |
| CN-108602820-A | Hetero-1, 5,6, 7-tetrahydro-4H-indol-4-ones | 拜耳制药股份公司 | 2018-09-28 | — | — | CN | claimed |
| WO-2009026422-A2 | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | ABBOTT LABORATORIES (US) | 2009-02-26 | — | — | WO | claimed |
| EP-2012787-A2 | COMBINATIONS COMPRISING BCR-ABL/C-KIT/PDGF-R TK INHIBITORS FOR TREATING CANCER | Novartis AG (CH) | 2009-01-14 | — | — | EP | claimed |
| CN-101340947-A | Combination of an iap-inhibitor and a taxane7 | NOVARTIS AG (CH) | 2009-01-07 | — | — | CN | claimed |
| US-20080166359-A1 | Methods of using MEK inhibitors | EXELIXIS, INC. | 2008-07-10 | — | — | US | claimed |
| WO-2008045905-A1 | PYRROLYDINE DERIVATIVES AS IAP INHIBITORS | NOVARTIS AG (CH) | 2008-04-17 | — | — | WO | claimed |
| WO-2007115289-A2 | COMBINATIONS COMPRISING BCR-ABL/C-KIT/PDGF-R TK INHIBITORS FOR TREATING CANCER | NOVARTIS AG (CH) | 2007-10-11 | — | — | WO | claimed |
| EP-1751108-A1 | ADAMANTYL-ACETAMIDE DERIVATIVES AS INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME | ABBOTT LABORATORIES (US) | 2007-02-14 | — | — | EP | claimed |
| WO-2005108368-A1 | ADAMANTYL-ACETAMIDE DERIVATIVES AS INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME | ABBOTT LABORATORIES (US) | 2005-11-17 | — | — | WO | claimed |
| US-20050080141-A1 | Amino diols useful in the treatment of alzheimer's disease | SCHOSTAREZ HEINRICH J (US) | 2005-04-14 | — | — | US | claimed |
| EP-0203031-A2 | Biologically active lysine containing octapeptides | The Administrators of The Tulane University Educational Fund (US) | 1986-11-26 | — | — | EP | claimed |